Patent US5020530A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5020530A Expired / Lapsed US ⏱️ 0.0 years remaining

Inhalation therapy device

Assignee: MOLDTRONICS Inc
•
Filing: 1990-05-07
•
Granted: 1991-06-04
•
Expires: 2010-05-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An inhalation therapy device has a first conduit joining a nebulizer to a patient breathing port, having a one way check valve. An expandable reservoir for receiving medication from the nebulizer joins the first conduit. A second conduit connected to the first conduit has a filter in a filter housing and a restricted orifice through which both inhalation from, and exhalation to, the atmosphere occurs.

Inventors

  • 👤 Warren C. Miller

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 11:53
CPC Classifications
A; A61; A61M; A61M16/00; A61M16/08; A61M15/00; A61M15/0001; A61M15/0013; A61M15/0016; A61M16/0816; A61M16/0833; A61M11/00; A61M11/06; A61M15/0086; A61M16/0057; A61M16/0078; A61M16/0087; A61M16/009; A61M16/0093; A61M16/10; A61M16/105; A61M16/1055

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 101 words
An inhalation therapy device comprising: (a) a nebulizer having an inlet adapted for connection to a positive pressure air source, a receptacle for receiving medication in liquid form to be nebulized, and an outlet for continuously dispensing the medication in aerosol form; (b) a patient breathing port; (c) a first conduit connecting the nebulizer outlet to the breathing port; (d) a check valve in the first conduit for permitting flow only in the direction from the nebulizer toward the breathing port. (f) a second conduit intersecting the first conduit between the check valve and the breathing port, and leading to atmosphere.
Claim 2
Dependent Claim 101 words
An inhalation therapy device comprising: (a) a nebulizer having an inlet adapted for connection to a positive pressure air source, a receptacle for receiving medication in liquid form to be nebulized, and an outlet for continuously dispensing the medication in aerosol form; (b) a patient breathing port; (c) a first conduit connecting the nebulizer outlet to the breathing port; (d) a check valve in the first conduit for permitting flow only in the direction from the nebulizer toward the breathing port. (f) a second conduit intersecting the first conduit between the check valve and the breathing port, and leading to atmosphere.
Claim 3
Dependent Claim 56 words
The device of claim 1, wherein the second conduit is provided with a restricted orifice, and is free from check valves so that inhalation at the breathing port in excess of the output of the nebulizer and reservoir will draw air in from atmosphere through the second conduit against the resistance provided by the restricted orifice.
Claim 4
Dependent Claim 27 words
The device of claim 2, wherein the first conduit is sealed except for its connection to the nebulizer outlet, patient breathing port, expandable reservoir and second conduit.
Claim 5
Dependent Claim 19 words
The device of claim 1, wherein the expandable reservoir has an expanded volume of at least about 1000 ml.
Claim 6
Dependent Claim 130 words
An inhalation therapy device comprising: (a) a nebulizer having an outlet, and an inlet adapted for connection to a positive pressure air flow source; (b) a patient breathing port; (c) a first conduit connecting the outlet of the nebulizer to the breathing port; (d) a check valve in the first conduit for permitting flow only in the direction from the nebulizer to the breathing port; (e) an expandable reservoir in communication with the first conduit; (f) a second conduit intersecting the first conduit between the check valve and the breathing port and leading to atmosphere; (g) a filter housing with filter interposed in the second conduit; and (h) a restricted orifice in the second conduit between the filter housing and atmosphere, adapted to pass air both to and from atmosphere.
Claim 7
Dependent Claim 130 words
An inhalation therapy device comprising: (a) a nebulizer having an outlet, and an inlet adapted for connection to a positive pressure air flow source; (b) a patient breathing port; (c) a first conduit connecting the outlet of the nebulizer to the breathing port; (d) a check valve in the first conduit for permitting flow only in the direction from the nebulizer to the breathing port; (e) an expandable reservoir in communication with the first conduit; (f) a second conduit intersecting the first conduit between the check valve and the breathing port and leading to atmosphere; (g) a filter housing with filter interposed in the second conduit; and (h) a restricted orifice in the second conduit between the filter housing and atmosphere, adapted to pass air both to and from atmosphere.
Claim 8
Dependent Claim 18 words
The device of claim 5, wherein the second conduit encloses a volume of at least about 65 ml.
Claim 9
Dependent Claim 14 words
The device of claim 5, further comprising a mouthpiece secured to the breathing port.
Claim 10
Dependent Claim 27 words
The device of claim 5, further comprising a coating on the interior walls of the nebulizer of a surface active agent for minimizing wetting of the walls.
Claim 11
Dependent Claim 55 words
In an inhalation therapy device including a nebulizer positioned in a breathing circuit for atomizing a liquid medication to be delivered to a patient's lungs, the improvement comprising a coating on the interior walls of the nebulizer comprising a surface active agent for minimizing deposition of the liquid medication on the walls of the nebulizer.
Claim 12
Dependent Claim 55 words
In an inhalation therapy device including a nebulizer positioned in a breathing circuit for atomizing a liquid medication to be delivered to a patient's lungs, the improvement comprising a coating on the interior walls of the nebulizer comprising a surface active agent for minimizing deposition of the liquid medication on the walls of the nebulizer.
Claim 13
Dependent Claim 19 words
The device of claim 9, wherein the surface active agent comprises the combination of an alcohol and a soap.
Claim 14
Dependent Claim 11 words
The device of claim 10, wherein the alcohol is isopropyl alcohol.
Claim 15
Dependent Claim 11 words
The device of claim 10, wherein the soap is an alkanolamine.

References Cited (Backward Citations)

US3967619A Cited
US4823784A Cited
US4823784B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-06-03 1994-12-03 1995-06-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-06-03 1998-12-03 1999-06-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-06-03 2002-12-03 2003-06-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag